Supernus Pharmaceuticals Inc. (SUPN) at a glance

Supernus Pharmaceuticals Inc. (SUPN) is a Healthcare company. It trades at $43.74. It does not pay a dividend. Vestovix scores it 50/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Income (40/100).

Price
$43.74
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$30.83 to $59.68
Vestovix Score50/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
46